HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ebelactone B

esterase inhibitor; structure given in first source; see also ebelactone A
Also Known As:
2-ethyl-3,11-dihydroxy-4,6,8,10,12-pentamethyl-9-oxo-tetradecenoic 1,3-lactone; 2-Oxetanone, 3-ethyl-4-(8-hydroxy-1,3,5,7,9-pentamethyl-6-oxo-3-undecenyl)-, (3S-(3alpha,4beta(1R*,3E,5S*,7R*,8S*,9S*)))-
Networked: 13 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Katori, Makoto: 2 articles (01/2014 - 01/2010)
2. Majima, Masataka: 2 articles (01/2014 - 01/2010)
3. Buning, Christian: 1 article (09/2012)
4. Hiss, Katrin: 1 article (09/2012)
5. Horstick, Georg: 1 article (09/2012)
6. Hübschle, Thomas: 1 article (09/2012)
7. Kannt, Aimo: 1 article (09/2012)
8. Kohlmann, Markus: 1 article (09/2012)
9. Kroll, Katja: 1 article (09/2012)
10. Linz, Dominik: 1 article (09/2012)

Related Diseases

1. Hypertension (High Blood Pressure)
2. Thrombosis (Thrombus)
3. Obesity
4. Infections
5. Renovascular Hypertension (Goldblatt Syndrome)

Related Drugs and Biologics

1. Salts
2. Desoxycorticosterone (Deoxycorticosterone)
3. Acetates (Acetic Acid Esters)
4. Desoxycorticosterone Acetate (DOCA)
5. Cathepsin A
6. Kinins
7. Exopeptidases (Exopeptidase)
8. Tissue Kallikreins (Tissue Kallikrein)
9. Sodium
10. Phosphotransferases (Kinase)

Related Therapies and Procedures

1. Therapeutics
2. Oral Administration